Opus Genetics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2014 | — | $26.6M | $9.8M |
| FY2015 | — | $18.8M | $10.2M |
| FY2016 | — | $17.1M | $11.6M |
| FY2017 | — | $16.8M | $8.9M |
| FY2018 | — | $-1.7M | $8.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2014 | — | $26.6M | $9.8M |
| FY2015 | — | $18.8M | $10.2M |
| FY2016 | — | $17.1M | $11.6M |
| FY2017 | — | $16.8M | $8.9M |
| FY2018 | — | $-1.7M | $8.7M |